Work

582 A phase I study of day 1 and 8 every three weeks docetaxel infusion

Year: 2003

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(03)90614-8

Authors: P.G. Giannessi, R. Di Marsico, F. Martella, C. Galli, F. Russo, A. Antonuzzo, M. Andreuccetti, A. Falcone

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2013299497

Cites:

Cited by:

Related to: 10